Undergraduate
Paul Clancy has been named to the board of directors of Agios Pharmaceuticals Inc. in Cambridge, Mass. Agios develops drugs that treat cancer and rare metabolic genetic diseases. Paul has been executive vice president and CFO at Biogen Idec since 2007.